Transitioning to Entyvio after achieving induction of remission with calcineurin inhibitor therapy is safe and effective for patients with ulcerative colitis, according to study results.

“While highly effective at inducing remission in patients with ulcerative colitis protracted use of calcineurin inhibitors [CNIs] is limited by adverse events, including infection, nephrotoxicity, hypercholesterolemia and hypertension. Consequently, their use in inflammatory bowel disease has been limited to induction therapy,” David T. Rubin, MD, section chief of gastroenterology, hepatology and…

Full Article: https://www.healio.com/gastroenterology/inflammatory-bowel-disease/news/online/4f6141ca-cd22-4ed3-8ba9-70aa8d52c837/switch-to-entyvio-after-calcineurin-inhibitor-induction-safe-effective-for-ulcerative-colitis